Although we found evidence of a decline in seroprevalence for antibodies against domain III of the envelope glycoprotein, as well as waning neutralizing antibody responses following two ZIKV outbreaks, the implications for susceptibility to future ZIKV infection remain unclear. This evidence concerns the gene ERVW-1 and Zika virus infectious disease.